Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 859341, 15 pages
http://dx.doi.org/10.1155/2014/859341
Review Article

Inductive and Deductive Approaches to Acute Cell Injury

1Department of Physiology, Wayne State University, 4116 Scott Hall, 540 East Canfield Avenue, Detroit, MI 48201, USA
2Department of Physics and Astronomy, Wayne State University, Detroit, MI 48201, USA

Received 5 March 2014; Accepted 25 June 2014; Published 12 October 2014

Academic Editor: Yun Wang

Copyright © 2014 Donald J. DeGracia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. E. O'Collins, M. R. Macleod, G. A. Donnan, L. L. Horky, B. H. Van Der Worp, and D. W. Howells, “1,026 Experimental treatments in acute stroke,” Annals of Neurology, vol. 59, no. 3, pp. 467–477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Kloner and L. Schwartz Longacre, “State of the science of cardioprotection: challenges and opportunities. Proceedings of the 2010 NHLBI workshop on cardioprotection,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 16, no. 3-4, pp. 223–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Dirnagl, “Bench to bedside: The quest for quality in experimental stroke research,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 12, pp. 1465–1478, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Fisher, G. W. Albers, G. A. Donnan et al., “Enhancing the development and approval of acute stroke therapies: stroke therapy academic industry roundtable,” Stroke, vol. 36, no. 8, pp. 1808–1813, 2005. View at Google Scholar
  5. M. Endres, B. Engelhardt, J. Koistinaho et al., “Improving outcome after stroke: overcoming the translational roadblock,” Cerebrovascular Diseases, vol. 25, no. 3, pp. 268–278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Röther, “Neuroprotection does not work!,” Stroke, vol. 39, no. 2, pp. 523–524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. DeGracia, Z. F. Huang, and S. Huang, “A nonlinear dynamical theory of cell injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 6, pp. 1000–1013, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. W. Muir, “Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design,” Stroke, vol. 33, no. 6, pp. 1545–1550, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Katz, An Introduction to the Special Theory of Relativity, Robert Katz Publications, D. Van Nostrand Company, 1964, http://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=1048&context=physicskatz.
  10. D. Newman, G. W. Ford, A. Rich, and E. Sweetman, “Precision experimental verification of special relativity,” Physical Review Letters, vol. 40, no. 21, pp. 1355–1358, 1978. View at Publisher · View at Google Scholar · View at Scopus
  11. B. G. Murray Jr., “Are ecological and evolutionary theories scientific?” Biological Reviews, vol. 76, no. 2, pp. 255–289, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Huang, “Back to the biology in systems biology: what can we learn from biomolecular networks?” Briefings in Functional Genomics and Proteomics, vol. 2, no. 4, pp. 279–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Lange, “Hume and the problem of induction,” in Handbook of the History of Logic, D. M. Gabbay, P. Thagard, and J. Woods, Eds., vol. 10 of Inductive Logic, pp. 43–91, Elsevier BV, 2008. View at Google Scholar
  14. J. D. Norton, “There are no universal rules for induction,” Philosophy of Science, vol. 77, no. 5, pp. 765–777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. G. Helfenbein and R. DeSalle, “Falsifications and corroborations: karl Popper's influence on systematics,” Molecular Phylogenetics and Evolution, vol. 35, no. 1, pp. 271–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. T. S. Kuhn, The Structure of Scientific Revolutions, vol. 1, University of Chicago Press, 1962.
  17. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Executive summary: heart disease and stroke statistics—2013 update: a report from the American heart association,” Circulation, vol. 127, no. 1, pp. 143–152, 2013. View at Google Scholar
  18. P. Tung and C. M. Albert, “Causes and prevention of sudden cardiac death in the elderly.,” Nature reviews. Cardiology, vol. 10, no. 3, pp. 135–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. O'Leary, “Comment on “Mode of death after admission to an intensive care unit following cardiac arrest” by Laver et al.,” Intensive Care Medicine, vol. 31, no. 6, p. 888, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Laver, C. Farrow, D. Turner, and J. Nolan, “Mode of death after admission to an intensive care unit following cardiac arrest,” Intensive Care Medicine, vol. 30, no. 11, pp. 2126–2128, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. A. Heidenreich, J. G. Trogdon, O. A. Khavjou et al., “Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association,” Circulation, vol. 123, no. 8, pp. 933–944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. American Heart Association Annual Financial Report, 2010, http://www.heart.org/idc/groups/heart-public/@wcm/@global/documents/downloadable/ucm_318583.pdf.
  23. “American Heart Association Annual Financial Report,” 2012, http://www.heart.org/idc/groups/heart-public/@wcm/@fin/documents/downloadable/ucm_446695.pdf.
  24. A. M. Miniño, S. L. Murphy, J. Xu, and K. D. Kochanek, “Deaths: final data for 2008,” National Vital Statistics Reports, vol. 59, no. 10, pp. 1–126, 2011. View at Google Scholar · View at Scopus
  25. N. Tajiri, T. Lau, L. E. Glover et al., “Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection,” Current Pharmaceutical Design, vol. 18, no. 25, pp. 3663–3669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Kim, H. Yim, S. Jeong, M. L. Klem, and C. W. Callaway, “Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms?: a systematic review and meta-analysis of randomized and non-randomized studies,” Resuscitation, vol. 83, no. 2, pp. 188–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Weant and S. N. Baker, “New windows, same old house: an update on acute stroke management,” Advanced Emergency Nursing Journal, vol. 34, no. 2, pp. 112–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Opitz and M. Schneider, “Über die sauerstoffversorgung des gehirns und den mechanismus von mangelwirkungen,” Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie, vol. 46, no. 1, pp. 126–260, 1950. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Symon, N. M. Branston, A. J. Strong, and T. D. Hope, “The concepts of thresholds of ischaemia in relation to brain structure and function.,” Journal of Clinical Pathology. Supplement, vol. 11, pp. 149–154, 1977. View at Google Scholar · View at Scopus
  30. J. Astrup, B. K. Siejo, and L. Symon, “Thresholds in cerebral ischemia—the ischemic penumbra,” Stroke, vol. 12, no. 6, pp. 723–725, 1981. View at Publisher · View at Google Scholar · View at Scopus
  31. K. A. Hossmann, “Viability thresholds and the penumbra of focal ischemia,” Annals of Neurology, vol. 36, no. 4, pp. 557–565, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Hossmann, “Experimental models for the investigation of brain ischemia,” Cardiovascular Research, vol. 39, no. 1, pp. 106–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. I. MacRae, “Preclinical stroke research—advantages and disadvantages of the most common rodent models of focal ischaemia,” British Journal of Pharmacology, vol. 164, no. 4, pp. 1062–1078, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Lipton, “Ischemic cell death in brain neurons,” Physiological Reviews, vol. 79, no. 4, pp. 1431–1568, 1999. View at Google Scholar · View at Scopus
  35. T. Back and O. G. Schüler, “The natural course of lesion development in brain ischemia,” Acta Neurochirurgica Supplement, vol. 89, pp. 55–61, 2004. View at Google Scholar · View at Scopus
  36. W. I. Rosenblum, “Histopathologic clues to the pathways of neuronal death following ischemia/hypoxia,” Journal of Neurotrauma, vol. 14, no. 5, pp. 313–326, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Kirino, “Delayed neuronal death,” Neuropathology, vol. 20, supplement 1, pp. S95–S97, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Hertz and G. A. Dienel, “Energy metabolism in the brain,” International Review of Neurobiology, vol. 51, pp. 1–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. I. S. Kass and P. Lipton, “Protection of hippocampal slices from young rats against anoxic transmission damage is due to better maintenance of ATP,” Journal of Physiology, vol. 413, pp. 1–11, 1989. View at Google Scholar · View at Scopus
  40. R. D. Patel and J. L. Saver, “Evolution of reperfusion therapies for acute brain and acute myocardial ischemia: a systematic, comparative analysis,” Stroke, vol. 44, no. 1, pp. 94–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Abou-Chebl, “Management of acute ischemic stroke.,” Current Cardiology Reports, vol. 15, no. 4, p. 348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. D. B. Zahuranec and J. J. Majersik, “Percentage of acute stroke patients eligible for endovascular treatment,” Neurology, vol. 79, supplement 1, no. 13, pp. S22–S25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. R. J. Myerburg, M. Velez, D. G. Rosenberg, J. Fenster, and A. Castellanos, “Automatic external defibrillators for prevention of out-of-hospital sudden death: effectiveness of the automatic external defibrillator,” Journal of Cardiovascular Electrophysiology, vol. 14, supplement 9, pp. S108–S116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. M. D. Ginsberg, “Neuroprotection for ischemic stroke: past, present and future,” Neuropharmacology, vol. 55, no. 3, pp. 363–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. D. J. DeGracia, “Towards a dynamical network view of brain ischemia and reperfusion. Part III: therapeutic implications,” Journal of Experimental Stroke and Translational Medicine, vol. 3, no. 1, pp. 90–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. G. Kanekar, T. Zacharia, and R. Roller, “Imaging of stroke: part 2, pathophysiology at the molecular and cellular levels and corresponding imaging changes,” American Journal of Roentgenology, vol. 198, no. 1, pp. 63–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Liu, H. Yuan, F. Yuan, and S. Yang, “Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke,” Neurological Research, vol. 34, no. 4, pp. 331–337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. C. Turner, S. C. Dodson, C. L. Rosen, and J. D. Huber, “The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success—a review,” Journal of Neurosurgery, vol. 118, no. 5, pp. 1072–1085, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. V. K. Siesjö, “Cell damage in the brain: a speculative synthesis,” Journal of Cerebral Blood Flow and Metabolism, vol. 1, no. 2, pp. 155–185, 1981. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Nicholson, “Measurement of extracellular ions in the brain,” Trends in Neurosciences, vol. 3, no. 9, pp. 216–218, 1980. View at Publisher · View at Google Scholar · View at Scopus
  51. I. A. Silver and M. Erecińska, “Intracellular and extracellular changes of [Ca2+] in hypoxia and ischemia in rat brain in vivo,” Journal of General Physiology, vol. 95, no. 5, pp. 837–866, 1990. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Kristián and B. K. Siesjö, “Calcium-related damage in ischemia,” Life Sciences, vol. 59, no. 5-6, pp. 357–367, 1996. View at Google Scholar
  53. J. Zhang, J. Yang, C. Zhang, X. Jiang, H. Zhou, and M. Liu, “Calcium antagonists for acute ischemic stroke,” Cochrane Database of Systematic Reviews, vol. 16, no. 5, Article ID CD001928, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. D. W. Choi, “Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage,” Trends in Neurosciences, vol. 11, no. 10, pp. 465–469, 1988. View at Publisher · View at Google Scholar · View at Scopus
  55. B. K. Siesjö and F. Bengtsson, “Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis,” Journal of Cerebral Blood Flow & Metabolism, vol. 9, no. 2, pp. 127–140, 1989. View at Publisher · View at Google Scholar · View at Scopus
  56. S. M. Davis, K. R. Lees, G. W. Albers et al., “Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist,” Stroke, vol. 31, no. 2, pp. 347–354, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Sugawara and P. H. Chan, “Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia,” Antioxidants and Redox Signaling, vol. 5, no. 5, pp. 597–607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. R. Chacon, M. B. Jensen, J. A. Sattin, and J. A. Zivin, “Neuroprotection in cerebral ischemia: emphasis on the SAINT trial,” Current Cardiology Reports, vol. 10, no. 1, pp. 37–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. S. I. Savitz and W. Schäbitz, “A critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke,” Stroke, vol. 39, no. 4, pp. 1389–1391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. G. J. del Zoppo, “The neurovascular unit in the setting of stroke,” Journal of Internal Medicine, vol. 267, no. 2, pp. 156–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Auriel and N. M. Bornstein, “Neuroprotection in acute ischemic stroke—current status,” Journal of Cellular and Molecular Medicine, vol. 14, no. 9, pp. 2200–2202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Brouns and P. P. de Deyn, “The complexity of neurobiological processes in acute ischemic stroke,” Clinical Neurology and Neurosurgery, vol. 111, no. 6, pp. 483–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. P. A. Barber, R. N. Auer, A. M. Buchan, and G. R. Sutherland, “Understanding and managing ischemic stroke,” Canadian Journal of Physiology and Pharmacology, vol. 79, no. 3, pp. 283–296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Kumar, S. Azam, J. M. Sullivan et al., “Brain ischemia and reperfusion activates the eukaryotic initiation factor 2alpha kinase, PERK,” Journal of Neurochemistry, vol. 77, no. 5, pp. 1418–1421, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Kumar, G. S. Krause, H. Yoshida, K. Mori, and D. J. DeGracia, “Dysfunction of the unfolded protein response during global brain ischemia and reperfusion,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 4, pp. 462–471, 2003. View at Google Scholar · View at Scopus
  66. D. J. DeGracia, R. Kumar, C. R. Owen, G. S. Krause, and B. C. White, “Molecular pathways of protein synthesis inhibition during brain reperfusion: implications for neuronal survival or death,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 2, pp. 127–141, 2002. View at Google Scholar · View at Scopus
  67. A. J. Fornace Jr., J. Jackman, M. C. Hollander, B. Hoffman-Liebermann, and D. A. Liebermann, “Genotoxic-stress-response genes and growth-arrest genes. gadd, MyD, and other genes induced by treatments eliciting growth arrest,” Annals of the New York Academy of Sciences, vol. 663, pp. 139–153, 1992. View at Publisher · View at Google Scholar · View at Scopus
  68. E. V. Maytin and J. F. Habener, “Transcription factors C/EBPα, C/EBPβ, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo,” Journal of Investigative Dermatology, vol. 110, no. 3, pp. 238–246, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. U. A. White and J. M. Stephens, “Transcriptional factors that promote formation of white adipose tissue,” Molecular and Cellular Endocrinology, vol. 318, no. 1-2, pp. 10–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. P. E. Lovat, M. Corazzari, B. Goranov, M. Piacentini, and C. P. F. Redfern, “Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells,” Annals of the New York Academy of Sciences, vol. 1028, pp. 81–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Oyadomari and M. Mori, “Roles of CHOP/GADD153 in endoplasmic reticulum stress,” Cell Death & Differentiation, vol. 11, no. 4, pp. 381–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. D. Ron and J. F. Habener, “CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription,” Genes and Development, vol. 6, no. 3, pp. 439–453, 1992. View at Publisher · View at Google Scholar · View at Scopus
  73. X. Wang, M. Kuroda, J. Sok et al., “Identification of novel stress-induced genes downstream of chop,” The EMBO Journal, vol. 17, no. 13, pp. 3619–3630, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Zinszner, M. Kuroda, X. Wang et al., “CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum,” Genes and Development, vol. 12, no. 7, pp. 982–995, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. S. J. Marciniak, C. Y. Yun, S. Oyadomari et al., “CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum,” Genes and Development, vol. 18, no. 24, pp. 3066–3077, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Han, S. H. Back, J. Hur et al., “ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death,” Nature Cell Biology, vol. 15, no. 5, pp. 481–490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Chapuisat, “Discussion of a simple model of spreading depression,” European Series in Applied and Industrial Mathematics Proceedings, vol. 18, pp. 87–98, 2007. View at Google Scholar
  78. G. Chapuisat, M. A. Dronne, E. Grenier, M. Hommel, H. Gilquin, and J. P. Boissel, “A global phenomenological model of ischemic stroke with stress on spreading depressions,” Progress in Biophysics and Molecular Biology, vol. 97, no. 1, pp. 4–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. C. Cross and P. C. Hohenberg, “Pattern formation outside of equilibrium,” Reviews of Modern Physics, vol. 65, no. 3, pp. 851–1112, 1993. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Huang, “Reprogramming cell fates: reconciling rarity with robustness,” BioEssays, vol. 31, no. 5, pp. 546–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. P. W. Sheppard, X. Sun, J. F. Emery, R. G. Giffard, and M. Khammash, “Quantitative characterization and analysis of the dynamic NF-κB response in microglia,” BMC Bioinformatics, vol. 12, article 276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. U. Dirnagl and A. Meisel, “Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?” Neuropharmacology, vol. 55, no. 3, pp. 334–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. D. J. DeGracia, “Towards a dynamical network view of brain ischemia and reperfusion. Part II: a post-ischemic neuronal state space,” Journal of Experimental Stroke and Translational Medicine, vol. 3, no. 1, pp. 72–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. D. J. DeGracia, “Towards a dynamical network view of brain ischemia and reperfusion. Part IV: additional considerations,” Journal of Experimental Stroke and Translational Medicine, vol. 3, no. 1, pp. 104–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. D. J. DeGracia, “Towards a dynamical network view of brain ischemia and reperfusion. Part I: background and preliminaries,” Journal of Experimental Stroke and Translational Medicine, vol. 3, no. 1, pp. 59–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. D. J. DeGracia, “A program for solving the brain ischemia problem,” Brain Sciences, vol. 3, no. 2, pp. 460–503, 2013. View at Google Scholar
  87. M. D. Pasic, S. Samaan, and G. M. Yousef, “Genomic medicine: new frontiers and new challenges,” Clinical Chemistry, vol. 59, no. 1, pp. 158–167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. R. B. Altman, “Personal genomic measurements: the opportunity for information integration,” Clinical Pharmacology and Therapeutics, vol. 93, no. 1, pp. 21–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Nicolini, N. Bragazzi, and E. Pechkova, “Nanoproteomics enabling personalized nanomedicine,” Advanced Drug Delivery Reviews, vol. 64, no. 13, pp. 1522–1531, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. D. M. Euhus and L. Robinson, “Genetic predisposition syndromes and their management,” The Surgical Clinics of North America, vol. 93, no. 2, pp. 341–362, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. J. A. Johnson and L. H. Cavallari, “Pharmacogenetics and cardiovascular disease-implications for personalized medicine,” Pharmacological Reviews, vol. 65, no. 3, pp. 987–1009, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. H. S. Markus, “Stroke genetics: prospects for personalised medicine,” BMC Medicine, vol. 10, article 113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. F. R. Sharp and G. C. Jickling, “Whole genome expression of cellular response to stroke,” Stroke, vol. 44, pp. S23–S25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. L. Rothstein and G. C. Jickling, “Ischemic stroke biomarkers in blood,” Biomarkers in Medicine, vol. 7, no. 1, pp. 37–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Goodacre, P. Thokala, C. Carroll et al., “Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome,” Health Technology Assessment, vol. 17, no. 1, pp. 1–210, 2013. View at Publisher · View at Google Scholar · View at Scopus